Study of Power Doppler Ultrasound (PDUS) to Measure Response of Secukinumab Treatment in Patients With Active Psoriatic Arthritis (PsA)
Clinical trial NCT02662985 · COMPLETED
Trial details
- NCT number
- NCT02662985
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-22
- Primary completion
- 2020-11-10
- Enrollment
- 166
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.